Literature DB >> 29651629

High-normal serum thyrotropin levels and increased glycemic variability in type 2 diabetic patients.

Jian-Bin Su1, Li-Hua Zhao2, Xiu-Lin Zhang3, Hong-Li Cai4, Hai-Yan Huang2, Feng Xu2, Tong Chen3, Xue-Qin Wang5.   

Abstract

PURPOSE: High-normal thyrotropin (TSH) is related to reduced insulin sensitivity and may contribute to glycemic disorders in diabetes. We investigated the relationship between normal serum TSH levels and glycemic variability in euthyroid type 2 diabetic patients.
METHODS: A total of 432 newly diagnosed type 2 diabetic patients with euthyroid function and normal serum TSH levels were recruited between March 2013 and February 2017. Insulin sensitivity was evaluated by the Matsuda index (ISIMatsuda) following a 75-g oral glucose tolerance test. Multiple glycemic variability indices, including the mean amplitude of glycemic excursions (MAGE), mean of daily differences (MODD), and standard deviation of glucose (SD), were calculated from glucose data obtained with a continuous glucose monitoring system. Average glucose accessed by 24-h mean glucose (24-h MG) was also calculated.
RESULTS: A normal serum TSH level was positively correlated with MAGE, MODD, SD, and 24-h MG (r = 0.206, 0.178, 0.186, and 0.132, respectively, p < 0.01). After adjusting for somatometric parameters, lipid profiles, ISIMatsuda, and HbA1c via multiple linear regression analysis, mean differences [B(95% CI)] in MAGE, MODD, SD, and 24-h MG between the patients in the lowest and highest quartiles of TSH levels were 0.128(0.031, 0.226), 0.085(0.022, 0.148), 0.039(0.001, 0.078), and 0.002(-0.264, 0.267) mmol/L, respectively. High-normal TSH was independently associated with MAGE, MODD, and SD, but not 24-h MG.
CONCLUSIONS: High-normal serum TSH is a significant additional risk factor for increased glycemic variability in type 2 diabetic patients.

Entities:  

Keywords:  Glycemic variability; Thyrotropin; Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29651629     DOI: 10.1007/s12020-018-1591-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  42 in total

1.  Higher free triiodothyronine is associated with non-alcoholic fatty liver disease in euthyroid subjects: the Lifelines Cohort Study.

Authors:  Eline H van den Berg; Lynnda J N van Tienhoven-Wind; Marzyeh Amini; Tim C M A Schreuder; Klaas Nico Faber; Hans Blokzijl; Robin P F Dullaart
Journal:  Metabolism       Date:  2016-11-06       Impact factor: 8.694

2.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

3.  Association Between Changes in Thyroid Hormones and Incident Type 2 Diabetes: A Seven-Year Longitudinal Study.

Authors:  Ji Eun Jun; Jae Hwan Jee; Ji Cheol Bae; Sang-Man Jin; Kyu Yeon Hur; Moon-Kyu Lee; Tae Hyuk Kim; Sun Wook Kim; Jae Hyeon Kim
Journal:  Thyroid       Date:  2016-12-09       Impact factor: 6.568

4.  Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study.

Authors:  S A P Chubb; W A Davis; T M E Davis
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

5.  Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.

Authors:  Annemieke Roos; Stephan J L Bakker; Thera P Links; Rijk O B Gans; Bruce H R Wolffenbuttel
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

6.  Glycemic variability is an important risk factor for cardiovascular autonomic neuropathy in newly diagnosed type 2 diabetic patients.

Authors:  Wen Xu; Yanhua Zhu; Xubin Yang; Hongrong Deng; Jinhua Yan; Shaoda Lin; Huazhang Yang; Hong Chen; Jianping Weng
Journal:  Int J Cardiol       Date:  2016-04-14       Impact factor: 4.164

7.  Thyroid function is associated with carotid intima-media thickness in euthyroid subjects.

Authors:  Noboru Takamura; Ainur Akilzhanova; Naomi Hayashida; Koichiro Kadota; Hironori Yamasaki; Toshiro Usa; Mio Nakazato; Takahiro Maeda; Yoshiyuki Ozono; Kiyoshi Aoyagi
Journal:  Atherosclerosis       Date:  2008-09-27       Impact factor: 5.162

8.  Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.

Authors:  Sri Venkata Madhu; Subrat Kumar Muduli; Rajnish Avasthi
Journal:  Diabetes Technol Ther       Date:  2013-04-30       Impact factor: 6.118

9.  The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases.

Authors:  Chaoxun Wang
Journal:  J Diabetes Res       Date:  2013-04-04       Impact factor: 4.011

10.  24-hour glucose profiles on diets varying in protein content and glycemic index.

Authors:  Marleen A van Baak
Journal:  Nutrients       Date:  2014-08-04       Impact factor: 5.717

View more
  1 in total

1.  High-Normal Serum Thyrotropin Levels Increased the Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects with Type 2 Diabetes.

Authors:  Ying Tan; Xixiang Tang; Panwei Mu; Yi Yang; Mei Li; Yuanpeng Nie; Haicheng Li; Yanhua Zhu; Yanming Chen
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-22       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.